| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0165-5728(00)00235-6 |
| P698 | PubMed publication ID | 10854647 |
| P2093 | author name string | Lund B | |
| McCarthy K | |||
| Weiner LP | |||
| McMillan M | |||
| Correale J | |||
| Ko DY | |||
| P2860 | cites work | Defining the clinical course of multiple sclerosis: Results of an international survey | Q22241638 |
| Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) | Q22241644 | ||
| Immunopathogenesis of multiple sclerosis: the role of T cells | Q33739582 | ||
| Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. | Q34253953 | ||
| Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure | Q34635952 | ||
| Immunological aspects of demyelinating diseases | Q35319665 | ||
| The cognitive paradigm and the immunological homunculus | Q35592137 | ||
| Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis | Q36368128 | ||
| Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells | Q36380346 | ||
| Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. | Q37476298 | ||
| Suppressor cell function in multiple sclerosis: Correlation with clinical disease activity | Q40711059 | ||
| Fas and FasL in the homeostatic regulation of immune responses | Q40957267 | ||
| Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients | Q41332725 | ||
| MHC-Restricted Depletion of Human Myelin Basic Protein-Reactive T Cells by T Cell Vaccination | Q41528229 | ||
| Induction of an anti-vaccine response by T cell vaccination in non-human primates and humans | Q41574700 | ||
| Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides | Q43794379 | ||
| Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis | Q45351794 | ||
| Isolation of myelin basic protein-reactive T-cell lines from normal human blood | Q46538947 | ||
| Myelination in rat brain: method of myelin isolation | Q48629501 | ||
| Interleukin-10 prevents experimental allergic encephalomyelitis in rats. | Q54205210 | ||
| Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. | Q54385154 | ||
| Lines of T Lymphocytes Induce or Vaccinate Against Autoimmune Arthritis | Q54503292 | ||
| Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein | Q59053168 | ||
| Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis | Q67533322 | ||
| T cell vaccination in multiple sclerosis: a preliminary report | Q68064747 | ||
| Vaccination against experimental autoimmune diseases using T lymphocytes treated with hydrostatic pressure | Q68980146 | ||
| Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis | Q69014541 | ||
| Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells | Q69073401 | ||
| Physiological basis of T-cell vaccination against autoimmune disease | Q69136260 | ||
| Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis | Q71710403 | ||
| IL-10 fails to abrogate experimental autoimmune encephalomyelitis | Q71726961 | ||
| Effects of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis | Q72219971 | ||
| Human CD8+ T lymphocyte clones specific for T cell receptor V beta families expressed on autologous CD4+ T cells | Q72641760 | ||
| Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms | Q73979411 | ||
| P433 | issue | 2 | |
| P921 | main subject | secondary progressive multiple sclerosis | Q18965511 |
| multiple sclerosis | Q8277 | ||
| P304 | page(s) | 130-139 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | Journal of Neuroimmunology | Q15716691 |
| P1476 | title | T cell vaccination in secondary progressive multiple sclerosis | |
| P478 | volume | 107 |
| Q37258223 | Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS |
| Q36327373 | Antigen-specific therapies in multiple sclerosis. |
| Q38154948 | Antigen-specific tolerization approaches in multiple sclerosis. |
| Q33620003 | Autoimmune T cell responses in the central nervous system |
| Q35861182 | Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines |
| Q37210493 | Autologous T-cell vaccination for multiple sclerosis: a perspective on progress |
| Q80455478 | CD28:B7 interaction is necessary for the protective effect of T cell vaccination in EAE |
| Q34596822 | CD4+ regulatory T cell responses induced by T cell vaccination in patients with multiple sclerosis |
| Q35982368 | CD8+ regulatory T cells induced by T cell vaccination protect against autoimmune nephritis |
| Q31047410 | Childhood multiple sclerosis: a review |
| Q35581158 | Emerging disease modifying therapies for multiple sclerosis |
| Q37559970 | Emerging immunopharmacological targets in multiple sclerosis |
| Q36868435 | Emerging therapies for MS. |
| Q37711026 | Exploring the roles of CD8(+) T lymphocytes in the pathogenesis of autoimmune demyelination |
| Q43104143 | Immunity and inflammation in neurodegenerative diseases |
| Q34566462 | Immunologic therapy for secondary and primary progressive multiple sclerosis |
| Q38083041 | Immunotherapy of multiple sclerosis: the state of the art. |
| Q89509904 | Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective |
| Q34590332 | MRI aspects of secondary progressive multiple sclerosis |
| Q46816215 | Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis |
| Q37313911 | Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary |
| Q37754616 | Novel therapeutic strategies targeting the pathogenic T-cells in multiple sclerosis |
| Q38008365 | Pathogenic CD8 T cells in multiple sclerosis and its experimental models |
| Q34986821 | Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects |
| Q34707921 | Primary progressive multiple sclerosis: increasing clarity but many unanswered questions |
| Q37039579 | Regulation of CD8+ regulatory T cells: Interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease |
| Q30574747 | Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells |
| Q26795528 | Role of T cell-glial cell interactions in creating and amplifying central nervous system inflammation and multiple sclerosis disease symptoms |
| Q37370531 | Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes |
| Q36359571 | T cell targeted immunotherapy for autoimmune disease |
| Q34524948 | T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial |
| Q42692324 | T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study |
| Q28209871 | T-cell vaccination for autoimmune disease: a panorama |
| Q30899568 | T-cell vaccination in multiple sclerosis |
| Q37755259 | T-cell-based immunotherapy in multiple sclerosis: induction of regulatory immune networks by T-cell vaccination |
| Q38237315 | The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review |
| Q37874615 | Tovaxin for multiple sclerosis |
| Q35936500 | Tregs in T cell vaccination: exploring the regulation of regulation |
| Q37085898 | Vaccines for multiple sclerosis: progress to date |
Search more.